How many insider declarations has ARCH Venture Fund XI, L.P. filed?

ARCH Venture Fund XI, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is ARCH Venture Fund XI, L.P.'s role?

ARCH Venture Fund XI, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does ARCH Venture Fund XI, L.P. report trades for?

ARCH Venture Fund XI, L.P. reports trades for DA32 Life Science Tech Acquisition Corp..

What is ARCH Venture Fund XI, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 13.5M€ and disposals 0.

← Executives ★ Sign in to follow

AV

ARCH Venture Fund XI, L.P.

Other

·SEC (Form 4)

DA32 Life Science Tech Acquisition Corp.

0

Total declarations

0

Company

€13m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 company, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €13.5m. Activity tracked since 30 July 2021. The latest transaction was filed on 30 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to ARCH Venture Fund XI, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

DA32 Life Science Tech Acquisition Corp. (US)

Declarations2 total

●

ARCH Venture Fund XI, L.P.

Executives28 Jul 2023DA32 Life Science Tech Acquisition Corp.

0SEC ↗

1,600,000 sharesClass A Common StockSEC:0001062993-23-016233:0

▲

ARCH Venture Fund XI, L.P.

Executives30 Jul 2021DA32 Life Science Tech Acquisition Corp.

$16M32SEC ↗

1,600,000 shares@ US$10.00100.0% of flowClass A Common StockSEC:0000899243-21-031417:0

Canonical exit: 28 Oct 2021 (T+90)

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AV

ARCH Venture Fund XI, L.P.

Other

·SEC (Form 4)

DA32 Life Science Tech Acquisition Corp.

0

Total declarations

0

Company

€13m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 company, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €13.5m. Activity tracked since 30 July 2021. The latest transaction was filed on 30 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.